As a supplier of professional diagnostic test kits, we understand that distributors and procurement partners need more than just product availability-they need assurance that every kit performs reliably in real-world clinical settings. This is especially critical for high-stakes infectious disease tests such as the dengue antigen test.
In this guide, we outline the systematic quality assurance measures we implement across manufacturing, validation, storage, and user support to ensure consistent, accurate performance of our test kits-including dengue antigen test, LH test kit, COVID-19 antibody test, and pregnancy test kit.
1. Manufacturing Quality Control
Ensuring proper test kit function begins with stringent quality control during production.
Raw Material Selection
We source only high-quality raw materials from qualified suppliers.
For the dengue antigen test, monoclonal antibodies and recombinant NS1 antigens are selected for high specificity to dengue virus serotypes (DENV 1–4).
Each batch of raw materials undergoes incoming quality inspection before production release.
Standardized Manufacturing Processes
Our production lines follow strict standard operating procedures (SOPs):
Reagent preparation, test strip assembly, and device packaging are conducted in controlled, contamination-free environments.
For dengue antigen test kits, nitrocellulose membrane coating and conjugate pad drying are precisely calibrated to ensure consistent sample flow and reaction kinetics.
In-Process Testing
We conduct multi-stage in-process testing:
Reagent functionality checks at critical production steps.
Physical integrity tests (e.g., strip width, membrane uniformity, desiccant humidity levels).
Batch-to-batch consistency monitoring to minimize variability.
2. Product Testing and Validation
Before any test kit is released for distribution, it undergoes rigorous analytical and clinical validation.
Analytical Validation
We assess key performance parameters including:
Sensitivity (Limit of Detection)
Specificity (cross-reactivity with other viruses)
Accuracy and precision
For the dengue antigen test, analytical validation includes testing against:
Dengue NS1 antigen reference standards
Potential cross-reactors (e.g., Zika, Chikungunya, Japanese encephalitis)
Clinical Validation
Real-world performance is confirmed through clinical studies:
We collaborate with reference laboratories and hospitals in endemic regions.
For dengue, clinical validation uses PCR-confirmed positive and negative patient samples across the acute febrile phase (Days 1–5 of symptom onset).
Performance metrics (sensitivity, specificity, positive/negative predictive value) are documented and available for distributor review.
Batch Release Testing
Every production batch undergoes final quality control testing before shipment, simulating real-use conditions.
3. Storage and Transportation Compliance
Proper cold chain management and storage conditions are critical for maintaining dengue antigen test performance. Distributors must adhere to our specifications.
Recommended Storage Conditions
Most rapid test kits, including the dengue antigen test, are stable between 2°C and 30°C when stored in original sealed packaging.
Avoid exposure to direct sunlight, heat, freezing, and high humidity (>80% RH).
Specific products requiring refrigeration are clearly labeled.
Transportation Guidelines for Distributors
We recommend the following during logistics:
Use insulated packaging and avoid prolonged exposure to extreme temperatures.
Monitor temperature during transit if shipping to hot or remote regions.
Upon receipt, inspect packaging integrity and check expiration dates before distribution to end-users.
Note for dengue antigen test distributors: Improper storage (e.g., heat >30°C for extended periods) may degrade NS1 capture antibodies, leading to false negative results. This should be clearly communicated to downstream clinics.
4. User Training and Technical Support
Even the highest-quality test kit can fail if used incorrectly. We provide robust distributor and end-user support.
Detailed User Manuals
Each kit includes a step-by-step instruction manual covering:
Specimen collection (whole blood, serum, or plasma for dengue antigen test)
Test procedure (sample volume, buffer drops, reading time)
Result interpretation (valid, positive, negative, invalid lines)
Storage and disposal
Distributor Support Services
We provide:
Technical documentation (IFU, COA, validation summaries) for regulatory submission.
Training materials (videos, posters, FAQs) for your downstream clients.
Dedicated customer support to answer questions on product handling or performance.
For the dengue antigen test, we can also arrange online training sessions focused on:
Early detection window (Days 1–5 of fever)
Limitations of NS1 testing (false negatives after Day 5)
Confirmatory testing recommendations (PCR or IgM)
5. Continuous Improvement Through Feedback and R&D
We are committed to ongoing product enhancement based on field performance data.
Customer Feedback Collection
We actively collect feedback from:
Distributors and procurement partners
Hospital laboratories and clinics
Public health programs using our kits
This feedback drives improvements in device design, instruction clarity, and packaging durability.
Research and Development (R&D)
We invest in R&D to:
Improve test sensitivity and specificity
Reduce cross-reactivity with related flaviviruses (e.g., Zika)
Enhance stability under tropical storage conditions
For the dengue antigen test, current R&D focuses on broadening serotype coverage and increasing detection sensitivity during the early febrile phase.
Conclusion
For medical distributors specializing in infectious disease diagnostics, product reliability is non-negotiable. By implementing rigorous quality control, clinical validation, cold chain compliance, and user training support, we ensure that our test kits-including the dengue antigen test, LH test kit, COVID-19 antibody test, and pregnancy test kit-deliver consistent, accurate results.
We are a trusted supplier of dengue antigen rapid test kits for the wholesale medical market.
If you are looking for a reliable partner with documented quality systems and responsive technical support, we invite you to contact us for product specifications, pricing, and distribution terms.
References
Clinical and Laboratory Standards Institute (CLSI). Evaluation of the Linearity of Quantitative Measurement Procedures; CLSI document EP06-A2.
World Health Organization (WHO). Guidelines for the evaluation of dengue diagnostics in the context of vaccine trials.
WHO/TDR. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control – New edition 2009 (updated).
European Centre for Disease Prevention and Control (ECDC). Dengue virus disease – diagnostic testing.